An evidence-based overview of cardio-oncology, focusing on cardiovascular risk, treatment-related cardiotoxicity, and long-term heart health in cancer survivors.

Dr. Tara Sanft, Director of the Cancer Survivorship Program at Yale Cancer Center and chair of the NCCN Survivorship Guidelines, reviews the research on patient-provider trust: why it matters, what it changes about clinical outcomes, and what the evidence says good providers actually do to earn it. Drawing on her work as Chief Patient Experience Officer at Smilow Cancer Hospital and her role directing Yale's Communication Skills Curriculum, she offers clinicians practical, evidence-based tools for building trust in the exam room — not just theory.

The WISDOM Study is redefining breast cancer screening, and the latest findings are practice-changing. Allison Stover Fiscalini, MPH, Executive Director of the Athena Breast Health Network and the WISDOM Study at UCSF, reviews Phase 1 results published in JAMA in December 2025 showing risk-based screening significantly reduced advanced-stage diagnoses compared to standard annual mammography, and introduces the goals of WISDOM 2.0. Free MNDG session, September 21.

Somewhere in your forties or fifties, sleep stopped being automatic. Maybe it's the 3 a.m. wakeups you can't explain, or the night sweats, or the fact that you're lying there doing math about how many hours you'll get if you fall asleep right now. Most women are told this is just what midlife looks like. Dr. Shelby Harris — a board-certified sleep psychologist and author of The Women's Guide to Overcoming Insomnia — disagrees. Join her for an hour on what perimenopause and menopause actually do to sleep, why trying harder makes it worse, what to make of melatonin and sleep trackers, and the treatment most women have never heard of. Wednesday, September 23, 8:00–9:00 PM ET, live and virtual.

Pediatric and adolescent gynecology sits at a unique intersection of developmental medicine, reproductive health, and patient-centered communication, requiring a skill set most non-specialist providers haven't been formally trained to deliver. Dr. Leslie Appiah, Professor and Chair of Obstetrics and Gynecology at Meharry Medical College, translates her deep clinical expertise into a practical framework covering normal pubertal development, menstrual disorders, congenital anomalies, and trauma-informed examination techniques. Free MNDG session, September 28.

OMC Monthly Case Rounds brings clinicians together once a month for a live working session on the hardest cases in oncology and menopause care — the ones where the guidelines run out and judgment has to fill the gap. Each session centers on real, de-identified patient cases contributed by the group, discussed in real time by peers who treat this population regularly. The series launches September 30 at 8:00 PM ET with Milana V. Dolezal, MD, MSci. This is a clinician-only session as part of OncoMenopause and the OncoMenopause Consortium®'s ongoing education programming, free to attend.

Perimenopause is one of the most clinically challenging phases of migraine management, marked by erratic estrogen fluctuations that can increase attack frequency, severity, and duration — often when treatment flexibility is limited. Dr. Katherine Hamilton, Assistant Professor of Neurology at MedStar Georgetown University Hospital, reviews the hormonal mechanisms driving these changes, evidence-based acute and preventive strategies, and the nuanced role of hormone therapy, with attention to patient selection and treatment sequencing. Free MNDG session, October 5.

Obesity medicine has shifted fast, and the headlines don't always match the clinical picture. Dr. Tracy Norfleet — a triple board-certified physician in internal medicine, obesity medicine, and lifestyle medicine — breaks down the newest medication options, what's changed in medical guidance, and how to separate genuine progress from hype. Join this free HERtalks session on October 7 at 8 PM ET for a clearer, shame-free look at where obesity care stands today.

Managing menopause is rarely straightforward, and for patients who don't fit neatly into clinical guidelines, the decisions get harder still. Dr. Risa Kagan, a Clinical Professor at UCSF with more than four decades of clinical practice, works through complex menopause cases — cardiovascular risk factors, hormone-sensitive cancer history, refractory vasomotor symptoms, and bone health concerns — walking attendees through her clinical reasoning and practical frameworks for the gray areas guidelines can't resolve. Free MNDG session, October 12.

Adult survivors of childhood cancer represent a growing and clinically complex population — one that women's health and oncomenopause providers are increasingly likely to encounter and often feel underprepared to serve. Drs. Eary and Erickson, whose careers are built around bridging the gap between oncology and survivorship primary care, deliver a practical, evidence-informed session on what clinicians need to know when these patients walk through their door.

Orgasmic function is one of the most under-addressed components of female sexual health in clinical practice, despite being among the concerns women most want their providers to address. Dr. Lauren Streicher, founder of the Center for Menopause and Sexual Health and a clinical professor at Northwestern's Feinberg School of Medicine, reviews the physiology, the impact of menopause and hormonal changes, and treatment options from estrogen and testosterone to emerging therapies. Free MNDG session, October 26.

Dr. Heather Quaile addresses HSDD, one of the most underdiagnosed conditions affecting women after cancer — what it is, how treatment contributes to it, and the evidence-based options available to help.

The era of one-size-fits-all breast cancer screening is ending, and radiomics and artificial intelligence are driving what comes next. Dr. Connie Lehman, Professor of Radiology at Harvard Medical School and Chief of Breast Imaging at Massachusetts General Hospital, reviews how AI-powered imaging analysis extracts biological signals invisible to the human eye, from deep learning models estimating five-year cancer risk to radiomic biomarkers complementing genomic data. Free MNDG session, November 2.

Non-hormonal menopause treatment has moved fast in recent years, and it can be hard to know what's actually available versus what's just headlines. Laurie Jeffers, DNP, FNP-BC, MSCP — cofounder of the Center for Midlife Health and Menopause at NYU Langone and a longtime Menopause Society leader — walks through the newer medication options and nonpharmacologic approaches shaping menopause care today. Join this free HERtalks session on November 4 at 8 PM ET for a clearer picture of what's worth asking your own doctor about.

Women still wait roughly a decade for an endometriosis diagnosis, and much of that delay happens in primary care and general gynecology, where cyclic pain gets normalized visit after visit. Hugh Taylor, MD — Anita O'Keeffe Young Professor and Chair of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, Chief of Ob/Gyn at Yale New Haven Hospital, and a member of the National Academy of Medicine — joins MNDG to talk through what should raise suspicion earlier, how medical management has changed, where surgery still belongs, and what the work on non-invasive diagnostics and precision treatment is likely to change. Monday, November 9, 8:00–9:00 PM ET.

An evidence-based review of menopause management strategies for gynecologic cancer survivors, with practical guidance for individualized, survivorship-centered care.

Counseling women at elevated breast cancer risk about menopausal hormone therapy is one of the most clinically nuanced conversations in women's health, and most providers lack a structured framework for it. Dr. Sabrina Sahni, a board-certified family medicine physician and Menopause Society Certified Practitioner specializing in the intersection of menopause and breast health, reviews how to stratify breast cancer risk and interpret MHT safety evidence across categories — including benign breast disease, dense breasts, and BRCA carriers — for individualized, shared decision-making conversations. Free MNDG session, November 16.

More patients now open the visit by naming the drug, which leaves the clinician evaluating a decision that has already been made. Dr. Lucy McBride has practiced primary care in Washington, DC for over twenty-five years and writes and speaks widely on treating mental and physical health as one clinical picture. Her November 18 MNDG session stays inside that visit: what to ask before prescribing, and how to respond when the request and the clinical problem don't line up. Free to attend.

Cancer-related menopause differs from natural menopause in onset and physiology, and the nutritional needs that follow differ too. Erin Pellegrin, RD, LDN, Senior Director of Culinary Nutrition and Education at Unite for HER, joins MNDG to present the culinary nutrition framework her team uses to counsel breast and ovarian cancer patients through treatment and survivorship — food-based approaches to common side effects, risk-reduction and cardiometabolic considerations, and where nutrition counseling fits into the broader care plan. She'll close with practical talking points clinicians can use when patients raise diet and weight change during survivorship visits.

Estradiol monitoring in women on menopausal hormone therapy remains one of the more contested and underutilized practices in clinical menopause care. Drs. Sarah Glynne and James Simon build the case for when and why estradiol level assessment matters — from optimizing symptom relief to informing individualized dosing decisions and managing safety in complex patients, including those with a breast cancer history — examining what the data actually supports versus where clinical judgment must fill the gaps. Free MNDG session, November 30.

Midlife metabolic changes aren't a personal failure, and the old advice to eat less and move more rarely tells the full story. Dr. Kimberley Sampson-Paine — a triple board-certified OB/GYN, obesity medicine specialist, and lifestyle medicine physician at Southwestern Vermont Medical Center — explains what's actually happening with hormones, weight, and insulin sensitivity at midlife, and what a more effective approach looks like. Join this free HERtalks session on December 2 at 8 PM ET for a clearer, more compassionate understanding of your changing body.

Nutrition and fitness guidelines are evolving, and the gap between what the evidence supports and what circulates on social media has never been wider or more consequential for clinical practice. Drs. Karl and Spencer Nadolsky, brothers who co-host the Docs Who Lift podcast, bring complementary expertise in endocrinology, obesity medicine, and digital health to a review of protein targets, resistance training recommendations, and updated dietary guidance, equipping clinicians to cut through the noise for their patients and themselves. Free MNDG session, December 7.

PCOS became PMOS this year, and the name change was never really about nomenclature. It was an acknowledgment that a condition affecting roughly one in ten reproductive-age patients is a lifelong cardiometabolic diagnosis, not a fertility problem with a cosmetic side. Basma Faris, MD, MS, FACOG, CCMS — Assistant Professor of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai, who came to medicine from clinical nutrition — joins WNDG to talk about what comprehensive PMOS care actually requires: metabolic screening, nutrition counseling that survives contact with a real patient's life, and long-term management in a system built around episodic visits. Wednesday, December 9, 8:00–9:00 PM ET.

Managing hereditary cancer risk requires more than a referral to genetics — it demands a clinical framework for longitudinal, multidisciplinary care across a woman's reproductive lifespan. Dr. Michelle Jacobson, Co-Director of the Familial Ovarian Cancer Clinic at Women's College Hospital in Toronto, reviews risk stratification across BRCA1/2 and other high-penetrance variants, the evidence for risk-reducing surgery and chemoprevention, surveillance strategies, and the intersection of menopause management and oncologic safety. Free MNDG session, December 14.

Dr. Mercedes Castiel walks through practical, take-home guidance for life after cancer: communicating with your care team, managing peri- and menopause symptoms, and risk-reducing strategies that fit your journey.

Thyroid disorders are among the most common endocrine conditions encountered in women's health practice, yet the nuances of postpartum thyroiditis, Hashimoto's thyroiditis, and Graves' disease are frequently misunderstood, misdiagnosed, or undertreated. Dr. Abid Yaqub, Associate Professor of Medicine at the University of Cincinnati College of Medicine, delivers an evidence-based update clarifying the distinct pathophysiology, presentation, and diagnostic approach for each condition, including monitoring during pregnancy, postpartum, and autoimmune overlap. Free MNDG session, December 21.